ACR: Sustained Clinical Responses Seen With Neuroimmune Modulation for RA

THURSDAY, Nov. 12, 2026-- Twenty-four-month data show sustained clinical responses for patients receiving neuroimmune modulation therapy for rheumatoid arthritis (RA), according to a study presented at the annual meeting of the American College of...